Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leiomyoma × Celecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 22 Breast Neoplasms 19 Carcinoma, Non-Small-Cell Lung 17 Lung Neoplasms 14 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Colonic Neoplasms 9 Prostatic Neoplasms 8 Pancreatic Neoplasms 6 Mouth Neoplasms 6 Glioblastoma 6 Neoplasm Metastasis 5 Esophageal Neoplasms 5 Central Nervous System Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Recurrence 4 Precancerous Conditions 4 Ovarian Neoplasms 4 Neuroblastoma 4 Gliosarcoma 4 Carcinoma 4 Adenomatous Polyposis Coli 4 Sarcoma 3 Oropharyngeal Neoplasms 3 Neoplasms 3 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Glioma 3 Carcinoma, Hepatocellular 3

Interventions

ulipristal acetate 11 Uterine Myomectomy 8 Uterine Artery Embolization 7 Tranexamic Acid 6 Bupivacaine 6 Mifepristone 5 Leuprolide 5 Saline Solution 4 Letrozole 4 Hysterectomy 4 epigallocatechin gallate 3 Sodium Chloride 3 Misoprostol 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 ulipristal 2 cetrorelix 2 Vitamin B 6 2 Tea 2 Tablets 2 Surveys and Questionnaires 2 Radiofrequency Ablation 2 Observation 2 Lidocaine 2 Hysteroscopy 2 Goserelin 2 Gonadotropins 2 Chorionic Gonadotropin 2 Anesthesia, General 2 tibolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01555073 2016-07-28

Preemptive Analgesia Following Uterine Artery Embolization

Northwestern University

Phase 4 Terminated

23 enrolled 6 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡